Published in Transplant Proc on February 01, 1995
Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection. Clin Exp Immunol (2000) 0.79
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature (2000) 4.66
Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet (2001) 4.60
The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion. Eur J Immunol (1988) 3.05
T lymphocyte adhesion to endothelial cells: mechanisms demonstrated by anti-LFA-1 monoclonal antibodies. J Immunol (1986) 2.28
Reopro removal during cardiopulmonary bypass using a hemoconcentrator. J Thorac Cardiovasc Surg (1999) 2.05
Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Clin Sci (Lond) (1989) 1.97
Cyclosporin-induced muscular toxicity. Lancet (1990) 1.41
Effects of bacterial lipopolysaccharide on the binding of lymphocytes to endothelial cell monolayers. J Immunol (1986) 1.41
Immunisation against hepatitis B in man. Lancet (1976) 1.31
Oxidative stress and gene expression: the AP-1 and NF-kappaB connections. Biofactors (2001) 1.30
Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet (1994) 1.30
Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation (1982) 1.27
Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int (2000) 1.25
Evolution, stress, and longevity. J Anat (2000) 1.22
Detection of left atrial thrombi by echocardiography. Br Heart J (1981) 1.21
Phorbol ester-stimulated T lymphocytes show enhanced adhesion to human endothelial cell monolayers. J Immunol (1986) 1.14
Pathways to chronic inflammation in rheumatoid synovitis. Fed Proc (1987) 1.14
Percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris: analysis of early and late results. Am Heart J (1983) 1.13
Detection of cytokines at the site of tuberculin-induced delayed-type hypersensitivity in man. Clin Exp Immunol (1992) 1.13
Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol (1993) 1.10
Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients. Am J Transplant (2007) 1.08
Scleritis as a presenting feature of Takayasu's disease. Br J Ophthalmol (2000) 1.08
Abnormalities in CD4+ T lymphocyte subsets in patients with common variable immunodeficiency. Clin Immunol Immunopathol (1991) 1.06
Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Med Biol (1997) 1.03
Interaction of cyclosporin and ticlopidine. Nephrol Dial Transplant (1991) 1.02
Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood (1996) 1.01
Intercellular adhesion molecule-1 (ICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in the bronchial mucosa of normal and asthmatic subjects. Eur Respir J (1992) 1.01
Superinduction of T lymphocyte-endothelial cell (EC) binding by treatment of EC with interleukin 1 and protein synthesis inhibitors. J Immunol (1987) 1.01
Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study. Lupus (2009) 0.98
[Arterial hypertension due to mercury poisoning: diagnostic value of captopril]. Arch Pediatr (1995) 0.95
[Wegener's disease mimicking acute infectious pleurisy]. Rev Pneumol Clin (2000) 0.94
Kidney damage due to tuberous sclerosis complex: management recommendations. Diagn Interv Imaging (2013) 0.93
Deficiency of CD4+CD45R+ T lymphocytes in common variable immunodeficiency. N Engl J Med (1990) 0.92
Novel antibodies associated with unexplained loss of renal allografts. Transpl Int (1990) 0.90
Visualising E-selectin in the detection and evaluation of inflammatory bowel disease. Gut (1998) 0.90
IL-4, but not tumor necrosis factor-alpha, increases endothelial cell adhesiveness for lymphocytes by activating a cAMP-dependent pathway. J Immunol (1993) 0.90
Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation. Cancer Immunol Immunother (1998) 0.90
Human NK cell-mediated direct and IgG-dependent cytotoxicity against xenogeneic porcine endothelial cells. Transpl Immunol (1996) 0.89
Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism. J Immunol (1999) 0.88
[Diffuse hypertrichosis caused by minoxidil in a 2-and-a-half-year-old child]. Ann Dermatol Venereol (1985) 0.87
Chronic renal failure and portal hypertension--is portosystemic shunt indicated? Pediatr Nephrol (2000) 0.86
Hypoestoxide, a novel anti-inflammatory natural diterpene, inhibits the activity of IkappaB kinase. Cell Immunol (2001) 0.86
Distribution of joint mobility in a normal population: results of the use of fixed torque measuring devices. Ann Rheum Dis (1986) 0.85
In vitro modulation of mouse natural killer (NK) cell activity by the serum thymic factor (FTS). Cell Immunol (1983) 0.85
Modulation of mouse natural killer cell activity by the serum thymic factor. Scand J Immunol (1982) 0.85
Compared TCR and CD3 epsilon expression on alpha beta and gamma delta T cells. Evidence for the association of two TCR heterodimers with three CD3 epsilon chains in the TCR/CD3 complex. J Immunol (1995) 0.84
Intercellular adhesion molecules in normal synovium. Br J Rheumatol (1993) 0.84
[A syndrome of hyper-IgE and recurrent infections. Developmental variants? A familial study]. Ann Dermatol Venereol (1984) 0.84
Evaluation in patients with Alport syndrome of knowledge of the disease and attitudes toward prenatal diagnosis. Clin Nephrol (1994) 0.84
Detection of circulating adhesion molecules in erythrodermic skin disease. J Am Acad Dermatol (1995) 0.84
End stage coronary disease treated with the transmyocardial CO2 laser revascularization: a chance for the 'inoperable' patient. Eur J Cardiothorac Surg (1997) 0.84
Association between the SDF1-3'A allele and high levels of CD34(+) progenitor cells mobilized into peripheral blood in humans. Br J Haematol (2001) 0.83
Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts. Effects of interferon-gamma, tumor necrosis factor alpha, and estrogen. Arthritis Rheum (1994) 0.83
Effects of severe protein restriction with ketoanalogues in advanced renal failure. J Am Coll Nutr (1999) 0.83
Circulating adhesion molecules in sarcoidosis. Clin Exp Immunol (1994) 0.83
Two-dimensional echocardiographic diagnosis of papillary muscle rupture. Chest (1981) 0.83
[Rheumatoid factors. Isotypes and severity of rheumatoid polyarthritis]. Rev Rhum Mal Osteoartic (1987) 0.83
Cluster of cases of haemolytic uraemic syndrome due to unpasteurised cheese. Pediatr Nephrol (1996) 0.83
Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat. Am J Pathol (1998) 0.82
Hepatitis B vaccine: efficacy in high-risk settings, a two-year study. Intervirology (1978) 0.82
Interleukin 4 and tumour necrosis factor alpha induce different adhesion pathways in endothelial cells for the binding of peripheral blood lymphocytes. Scand J Immunol (1992) 0.82
Tissue factor activity of syncytiotrophoblast plasma membranes and tumoral trophoblast cells in culture. Thromb Haemost (1995) 0.81
ELISA for the detection of anticardiolipin antibodies. High specificity based on the use of adult bovine serum as buffer and systematic subtraction of non-specific binding. J Immunol Methods (1991) 0.81
Removal of terminal alpha-galactosyl residues from xenogeneic porcine endothelial cells. Decrease in complement-mediated cytotoxicity but persistence of IgG1-mediated antibody-dependent cell-mediated cytotoxicity. Transplantation (1996) 0.81
Early pulse pressure and low-grade proteinuria as independent long-term risk factors for new-onset diabetes mellitus after kidney transplantation. Am J Transplant (2008) 0.81
Neocortical lateralization of NK activity in mice. Scand J Immunol (1981) 0.80
Morphometric investigations in mitral stenosis using two dimensional echocardiography. Br Heart J (1982) 0.80
Treatment of unstable angina pectoris with percutaneous transluminal coronary angioplasty (PTCA). Cathet Cardiovasc Diagn (1981) 0.80
A simplified and low-cost one-stage chromogenic assay for tissue factor dependent procoagulant activity of endothelial cells. Thromb Res (1995) 0.80
[Bartter's syndrome: seven cases in siblings. Hypothesis of mild forms (author's transl)]. Nouv Presse Med (1980) 0.80
Pathogenetic factors in rheumatoid synovitis. Br J Rheumatol (1988) 0.80
[Guidelines for the management of tuberous sclerosis complex renal disease]. Prog Urol (2012) 0.80
[Biochemical study of the glycoproteins of the glomerulus basement membrane of the human kidney hydrolysed with collagenase (author's transl)]. Clin Chim Acta (1973) 0.79
Serial study of T-lymphocyte subsets in women during very early pregnancy. Clin Immunol Immunopathol (1988) 0.79
Effect of human inflammatory cytokines on porcine endothelial cell MHC molecule expression: unique role for TNF-alpha in MHC class-II induction. Transplant Proc (1994) 0.79
Hodgkin's disease following steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol (1994) 0.79
The inhibitory effect of human syncytiotrophoblast plasma membrane vesicles on in vitro lymphocyte proliferation is associated with reduced interleukin 2 receptor expression. Cell Immunol (1991) 0.79
Induction of Jurkat T-cell apoptosis by Fas ligand-transfected endothelial cells. Transplant Proc (2000) 0.79
New developments in medical-surgical treatment of acute myocardial infarction. Ann Thorac Surg (1983) 0.79
Lectin-like activity of components extracted from human glomerular basement membrane. Proc Natl Acad Sci U S A (1979) 0.79
[Is smoking history a risk factor of arterial hypertension in men?]. Arch Mal Coeur Vaiss (2000) 0.79
[Hepatitis A of children. Seroepidemiological study among French urban population (author's transl)]. Nouv Presse Med (1979) 0.79
Circulating adhesion molecules in asthma. Am J Respir Crit Care Med (1994) 0.79
Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription-polymerase chain reaction. Thromb Res (1999) 0.79
[Late onset cystinosis. Apropos of a case]. Nephrologie (1987) 0.78
Improving wedged field dose distributions. Phys Med Biol (1997) 0.78
[Study of the nephrotoxicity of antibodies directed against the glomerular basement membrane glycoproteins of the Wistar rat]. C R Acad Sci Hebd Seances Acad Sci D (1976) 0.78
Nephrotoxic potency of antisera to three rat glomerular basement membrane glycoproteins. Clin Exp Immunol (1978) 0.78
Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyte-endothelial cell adhesion. Transplantation (1996) 0.78
Correlation of plasma hormone levels and peripheral circulating lymphocyte subpopulations during human pregnancy. Immunol Lett (1984) 0.78
Flow characteristics in single and sequential aorto-coronary by-pass grafts. J Cardiovasc Surg (Torino) (1984) 0.78
Cystinosis encephalopathy: MRI perivascular enhancement with micronodular T2* hypointensity. Diagn Interv Imaging (2013) 0.78
Docosahexaenoic and eicosapentaenoic acids inhibit human lymphoproliferative responses in vitro but not the expression of T cell surface activation markers. Scand J Immunol (1996) 0.78